- 3-6 months initial treatment
- Ongoing management with improvement in 8-12 weeks
- 73%
China versus the U.S.
- China clinical rate
- $800 – $4,000
- $2,400
- United States
- $3,000 – $15,000
- $9,000
- You save
- ~73%
- $6,600 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Comprehensive rheumatoid arthritis treatment combining DMARDs, biologics, and traditional Chinese medicine approaches. China's top rheumatology centers offer advanced biologic therapies including TNF inhibitors and IL-6 blockers at significantly lower costs. Integrated TCM therapies such as acupuncture and herbal medicine provide additional symptom relief and immune modulation.
Step by step.
Comprehensive Assessment
Full rheumatologic evaluation including joint imaging, inflammatory markers (ESR, CRP), and autoantibody testing (RF, anti-CCP)
DMARD Initiation
Start disease-modifying antirheumatic drugs (methotrexate, leflunomide) with monitoring protocols
Biologic Therapy
If inadequate response, initiate targeted biologic agents (adalimumab, tocilizumab, or JAK inhibitors)
Integrated TCM Support
Complementary acupuncture, moxibustion, and herbal formulas to reduce inflammation and improve joint mobility
- 60-70% cost savings compared to Western countries
- Access to both biologics and traditional Chinese medicine
- Experienced rheumatologists at major university hospitals
- Comprehensive monitoring and dose adjustment protocols
- Increased infection risk from immunosuppression
- Potential liver toxicity from DMARDs requiring monitoring
- Allergic reactions to biologic agents
- Treatment may require long-term commitment
Ask the AI for hospitals that handle rheumatoid arthritis treatment.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.